Latest News

You can find our latest news below

04 Oct, 2024

We will be attending Medica 2024 in mid-November.

27 Sep, 2024

Cardiac troponins I (cTnI) and T (cTnT) are established biomarkers of acute myocardial infarction (AMI). Together with troponin С (TnC), they form a ternary troponin complex (ITC-complex) that represents a significant portion of troponins released into the bloodstream following cardiomyocyte necrosis

09 Aug, 2024

In this latest article, the authors further discuss the effects of heparin on the measurement of cardiac isoforms of cTnI and cTnT.

27 Jun, 2024

As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued tr As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued trust and support. ust and support.

27 Jun, 2024

To help find better solutions in tackling tumor cancers investigations, we are very much delighted to announce that our new product, mouse monoclonal antibody (MAb) 1X5cc is launched today!

26 Jun, 2024

In collaboration with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the European Federation of Laboratory Medicine (EFLM), Hytest has proudly demonstrated its commitment to advancing scientific research in the field of cardiovascular diseases. By sponsoring awards, Hytest has consistently recognized and honoured outstanding work in cardiovascular diagnostics. 

19 Jun, 2024

We will be attending the 2024 ADLM Clinical Lab Expo from July 28 to August 1.

18 Jun, 2024

By choosing to buy locally, you not only support the North American branch but also ensure a smoother, more cost-effective purchasing experience.

10 Jun, 2024

We are excited to announce the launch of a new recombinant Anti-CA-125 antibody RX16 (Cat# 4C29).

29 May, 2024

May is Cancer Survivor Month. We honor the strength, resilience, and courage of cancer survivors around the world.

15 May, 2024

We are excited to announce the launch of a new recombinant Glial Fibrillary Acidic Protein (GFAP) antigen, Cat# 8G47.

11 Apr, 2024

Hytest is pleased to announce the addition of recombinant monoclonal antibodies RC3A6 and RC8E2 (Cat. # 2I1) to our Insulin product portfolio.

28 Mar, 2024

Our monoclonal antibodies (MAbs) can recognize up to 16 different strains of the influenza A virus. 

01 Mar, 2024

Meet HyTest team at the China Association of Clinical Laboratory Practice Expo!

01 Mar, 2024

Launch of HyTest’s latest monoclonal antibodies targeting the nucleoprotein of influenza B virus!

01 Mar, 2024

The Brain Injury Association of America (BIAA) designates March as a month to raise awareness about brain injuries.

01 Mar, 2024

We are pleased to inform you that Hytest North America, a subsidiary of Hytest Ltd, will launch local operations in March 2024!

31 Jan, 2024

February is American Heart Month, emphasizing the importance of heart health, with a focus on women this year due to their unique risk and often underdiagnosed heart conditions. Current AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain highlight the gender-specific nature of heart disease diagnosis, particularly noting that women generally have lower baseline levels of troponin.

At HyTest, we are dedicated to meeting this gender-specific diagnostic need through our innovations in cardiac diagnostics, especially in troponins. Our product range includes approximately 50 antibodies targeting various epitopes of the cardiac troponin I (cTnI) molecule, complemented by our advanced cardiac troponin and troponin complex antigens. For more detailed information, please refer to our Cardiac Markers Brochure.

04 Jan, 2024

HyTest antibodies should recognize Pirola and Eris variants.

19 Dec, 2023

Procollagen type I N-propetide (PINP) in blood is recommended as a reference marker for bone formation in osteoporosis by the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry (IFCC) bone marker standards joint working group. PINP, in particular, has emerged as a recommended reference marker for bone formation in osteoporosis, aiding in monitoring antiresorptive and anabolic therapies.

Do you need samples?

We are happy to make you an offer